Associated Papers
Integrating evidence from protein domains to identify cancer driver mutations.
Ostroverkhova D et al.
Protein Science : a Publication of the Protein Society, 2026
41556616 (PubMed )
Supplement: PRO-35-e70422-s002.xlsx › Table_S1
Somatic mutations in the TG and RELA genes specific for radioiodine-refractory thyroid cancer.
Sukprakun C et al.
Scientific Reports, 2025
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
Murphy AJ et al.
Nature Communications, 2023
38110397 (PubMed )
Supplement: 41467_2023_43730_MOESM5_ESM.xlsx › COG
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Sakthikumar S et al.
Veterinary and Comparative Oncology, 2023
37248814 (PubMed )
Supplement: supplement_1.xlsx › Supp._Table_5
Prognostic Indicators of EIF1AX-Mutated Thyroid Tumor Malignancy and Cancer Aggressiveness.
Bandargal S et al.
Cancers, 2022
Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.
Umeda M et al.
Blood Cancer Discovery, 2022
35176137 (PubMed )
Supplement: bcd-21-0160_supplemental_tables_supp1-32.xlsx › Table_S12_SNV_indel
NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.
Gong XY et al.
Frontiers in Immunology, 2022
35911687 (PubMed )
Supplement: DataSheet_1.zip › onco500_qc_pass_20211125-42.xlsx › somatic
Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.
Sebastiao APM et al.
Histopathology, 2019
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
Yoo SK et al.
Nature Communications, 2019
31235699 (PubMed )
Supplement: 41467_2019_10680_MOESM5_ESM.xlsx › Supplementary_Data_2
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.
Etemadmoghadam D et al.
Cancer Research, 2017
28646021 (PubMed )
Supplement: 00085472can162224-sup-170263_3_unknown_upload_4011671_jp98gb.xlsx › Table_S11
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Wei L et al.
Oncotarget, 2016
27823983 (PubMed )
Supplement: oncotarget-07-76374-s002.xlsx › 2
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
Xu B et al.
Endocrine Pathology, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Landa I et al.
The Journal of Clinical Investigation, 2016
The Value of Detecting and Monitoring ctDNA in Uveal Melanoma: Results of a Pilot Study and a Systematic Review.
Azimi F et al.
Case Reports in Ophthalmology, 0
Select a paper to view details